ALX ONCOLOGY HOLDINGS INC Conversion of Stock, Amount Converted
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Conversion of Stock, Amount Converted of $175.04 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountConverted1 · last filed 2023-03-09
- ALX ONCOLOGY HOLDINGS INC conversion of stock, amount converted for the quarter ending 2020-12-31 was $0.00.
- ALX ONCOLOGY HOLDINGS INC conversion of stock, amount converted for fiscal 2020 was $175.04M.
| Period end | Conversion of Stock, Amount Converted 3 month | Conversion of Stock, Amount Converted 9 month | Conversion of Stock, Amount Converted 12 month |
|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $175.04M 10-K · filed 2023-03-09 | |
| 2020-09-30 | $175.04M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |